Following the European Society for Medical Oncology (ESMO) Congress 2024, Samantha Armstrong, MD, Indiana University, and co-host of the podcast “Two Onc Docs,” offers a review of two genitourinary (GU) oncology abstracts that were presented. A notable, practice-changing abstract was the NIAGARA trial presented by Dr. Thomas Powles at the Presidential Symposium on Sunday, September 15. This study involved 1,063 patients with muscle-invasive bladder cancer eligible for platinum-based chemotherapy followed by radical cystectomy. Patients were randomized 1:1 to receive either standard ...